⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of MedHub-AI and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
MedHub-AI
↗Tel Aviv, Israel
MedHub-AI is a medical technology company that develops AI-based deep learning algorithms for medical video systems. Its flagship product, AutocathFFR™, is a diagnostic tool designed to assist interventional cardiologists by providing automated, non-invasive assessment of coronary artery stenosis.
The company focuses on streamlining cardiac catheterization procedures, aiming to reduce the need for invasive supplementary diagnostic interventions. MedHub-AI has established a presence in international markets, including Japan, where it has received regulatory approval and reimbursement for its technology.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Medical Decision Support / Cardiology
SIZE & FINANCIALS
Employees:1-50
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Seed
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (AutocathFFR™)
Modalities:AI/Software
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Terumo Medical (Marketing partnership in Japan)
COMPETITION
Position:Emerging
Competitors:HeartFocus, Powerful Medical, Volta Medical
LEADERSHIP
Key Executives:
Or Bruch El - CEO & Co-Founder
Scientific Founders:Or Bruch El, David Goldman
Board Members:Rafael Beyar
LINKS
Website:medhub-ai.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with MedHub-AI. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.